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1. Introduction 
Many of the protease inhibitors in plasma form 
extremely stable complexes with proteolytic enzymes, 
which cannot be dissociated by strong denaturating 
agents [1-4]. Many of these complexes are, however, 
dissociated by nucleophilic agents; acovalent bond 
may be involved in their stabilization [1,2]. This has 
also been suggested for inhibitors uch as soybean 
trypsin inhibitor and aprotinin in their complexes 
with proteases [5,6]. The reaction between plasmin 
and ct2-antiplasmin was investigated by a number of 
kinetic [7-9] and structural studies [10]. The kinetic 
data have revealed a two-step reaction: (i) a very fast 
reversible second-order reaction; followed by (ii) a 
slower irreversible transition [7-9]. The structural 
data have indicated that the reactive site in a2-anti- 
plasmin constitutes a specific leucyl-methionyl resi- 
due in the carboxy-terminal portion of the molecule 
[ 10]. a2-Antiplasmin and its interactions are reviewed 
in [11]. This study was done to investigate whether 
the reactive site in az-antiplasmin is cleaved as a result 
of complex formation with plasmin. Part of this work 
has been presented in [12]. 
2. Materials and methods 
2.1. Plasminogen 
Glu-plasminogen was purified by affinity chroma- 
tography on lysine-Sepharose [13] followed by 
DEAE-Sephadex A-50 chromatography [14]. It was 
characterized by SDS-polyacrylamide g lelectropho- 
resis and NH2-terminal mino acid determination. 
* To whom eorrespondence should be addressed 
2.2. a2-Antiplasmin 
a2-Antiplasmin was purified by affinity chromatog- 
raphy on LBS I-Sepharose followed by gel-fdtration 
on Ultrogel AcA 44, as in [11,15]. LBS I is a fragment 
from plasminogen constituting the 3 NH2-terminal 
triple-loop structures obtained after digestion with 
elastase [ 16]. The material was characterized bySDS- 
polyacrylamide g l electrophoresis and NH2-terminal 
amino acid analysis and found to fulfill the specifica- 
tions in [ 15 ]. 
2.3. Complexes between Glu-plasmin and protease 
ip~ffbitors 
To obtain Glu-plasmin complexes with a2-antiplas- 
min or soybean trypsin inhibitor, a mixture of Glu-  
plas~.dnogen (final conc. ~10 mg/ml) and the inhibitor 
in ~50% molar excess were dissolved in 0.1 M sodium 
phosphate buffer (pH 7.3). Activation was performed 
by the addition of urokinase (final conc. 2500 1U/ml) 
and incubation at room temperature for 2 h. The 
material was subsequently dialyzed extensively against 
distilled water at +5°C and lyophilized. 
2.4. R eagen ts 
Soybean trypsin inhibitor was purchased from 
Sigma (St Louis MO). Urokinase was a gift from 
Choay (Paris, courtesy of Dr F. Toulemonde). Na~2SI 
was from Kebo AB (Stockholm) and 3H-labelled phen- 
ylisothiocyanate from The Radiochemical Centre 
(Amersham). All other reagents were of analytical 
grade. 
2.5. SDS-polyacrylamide g l electrophoresis 
This was performed essentially as in [ 17] using 7% 
polyacrylamide g ls on reduced as well as non-reduced 
samples. After staining, the gels containing 12SI-labelled 
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material were cut into slices representing the different 
interesting protein bands and the radioactivity was 
counted in a Multigamma counter (LKB, Stockholm). 
plasmin complex, besides the expected NH2-terminal 
amino acids (glutamic acid, valine and aspargine) 
methionine was also found at ~l  mol/mol complex. 
2.6. NH2-terminal mino acid analysis 
NH2-Terminal amino acids were determined by 
manual Edman degradation essentially as in [18]. The 
phenylthiohydantoin amino acid derivatives were 
identified by thin-layer chromatography on silica gel 
plates, as in [ 19 ]. Radioactive derivatives were quan- 
titatedby scraping off the silica containing the different 
spots, adding 5 ml scintillation liquid (Instagel, 
Packard Instruments) and counting in a liquid counter 
(Intertechnique, SL4000). Quantitation of amino 
acid phenylthiohydantoin derivatives were performed 
by amino acid analysis (LKB, Biochrom 4400) after 
hydrolysis for 4 h at 150°C in 6 M HCI containing 
0.1% stannous chloride [20]. 
3.  Resu l t s  
3.1. NH2-terminal mino acids in soybean trypsin 
inhibitor or a2-antiplasmin in complex with 
plasmin 
As a first step to find out the nature of the stabiliz- 
ing bond in different plasmin-inhibitor complexes, 
these were subjected to NH2-terminal mino acid 
determination. About equal amounts of glutamic acid, 
valine and aspartic acid in -~1 mol/mol soybean trypsin 
inhibitor-plasmin complex were found (table 1). 
This represents he NH2-terminal mino acid in the 
parent molecules. However, in the plasmin-a2-anti- 
Table 1 
Amino acid a b c d 
Aspartic acid - 1.5 2.2 1.0 
Glutamic acid 0.9 0.7 0.7 - 
Valine - 1.0 1.0 - 
Meth ion ine  0.1 0.1 1.0 - 
Isoleucine - 0.1 0.1 - 
NH2-terminal mino acids in: plasminogen (a); the complex 
between plasmin and soybean trypsin inhibitor, obtained by 
activation of plasminogen in ~50% molar excess of the inhib- 
itor (b); plasmin-a2-antiplasmin complex obtained by incu- 
bation (16 h) of the plasmin-soybean trypsin inhibitor com- 
plex (50% excess inhibitor) with an equimolax amount of 
a2-antiplasmin (c); soybean trypsin inhibitor obtained after 
dissociation ofthe soybean trypsin inhibitor-plasmin com- 
plex by ~2-antiplasmin (d). Figures axe expreseed in mol/mol 
protein (a,d) or mol/mol complex (b,c) 
3.2. Dissociation of soybean trypsin inhibitor- 
plasmin complex in the presence of a2-antiplasmin 
If soybean trypsin inhibitor-plasmin complex is 
mixed with ct2-antiplasmin i molar excess the plasmin 
is completely transferred into a complex with t~2-anti- 
plasmin. The NH2-terminal mino acids in such a com- 
plex are demonstrated in table 1. By gel-ffdtration on 
Ultrogel AcA 44 in 0.1 M NH4HCOa the plasmin- 
a2-antiplasmin complex can be separated from the 
released soybean trypsin inhibitor. Only NH:-terminal 
aspartic acid is found in the latter inhibitor-moiety, 
which is identical to the native soybean trypsin inhib- 
itor preparation. Furthermore, analysis of the released 
soybean trypsin inhibitor by SDS-polyacrylamide g l 
electrophoresis (reduced and non-reduced samples) 
demonstrated a single chain molecule with a mobility 
identical to that of the native molecule. Analysis of 
its inhibitory activity against plasmin revealed that 
~90% activity was retained. 
To exclude the possibility of secondary proteolytic 
cleavage by plasmin as a cause of peptide bond cleav- 
age in a2-antiplasmin during its reaction with plasmin, 
the following experiments were undertaken. ~2sI- 
Labelled Glu-plasmin in complex with soybean trypsin 
inhibitor was dissolved in 4.5% (v/v) dimethylallylamine 
buffer (adjusted with trifluoroacetic acid to pH 8.0) 
to 10 mg/ml final cone. and mixed with an equal 
volume of a2-antiplasmin solution (9 mg/ml in the 
same buffer). At different imes, over 0 -4  h, samples 
were taken for SDS-polyacrylamide g l electropho- 
resis and for NH2-terminal mino acid determination. 
After staining the gels, the bands comprising plasmin 
and plasmin-a2-antiplasmin complex were cut out 
and counted for radioactivity. From the results, 
shown in fig.l, the dissociation of the soybean trypsin 
inhibitor-plasmin complex was found to obey first- 
order kinetics with a half-life of ~60 rain, which 
equals a rate constant of 2 × 10 -~ s -1. Within experi- 
mental error, the appearance of methionine as new 
NH2-terminal mino acid is concomitant with the for- 
mation of the plasmin-a2-antiplasmin complex (fig. 1 ). 
3.3. Pulse labelling of plasmin-a2-antiplasmin with 
[ aH]phenylisothiocyanate 
In an attempt to show that NH2-terminal methio- 
nine is not produced uring the coupling step of the 
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Fig.1. Dissociation of the plasmin-soybean trypsin inhibitor 
complex in the presence of a2-antiplasmin as demonstrated 
by the formation of plasmin-%-antiplasmin complex (o - -o )  
and the appearance of new NH2-terminal methionine ( . - -~) .  
For details of the experiments see text. The figures are given 
as ratios between the plasmin-cq-antiplasmin complex/the 
initial plasmin-soybean trypsin inhibitor complex and 
methionine/valine, respectively. 
NH2-terminal mino acid analysis, but exists in the 
native complex, apulse-labelling experiment with 
[3H]phenylisothiocyanate wasdone. For this purpose 
plasmin---a2-antiplasmin complex was dissolved in 
0.01 M sodium phosphate buffer (pH 7.8) to 20 rag/ 
ml final conc. and divided into 250 gl aliquots. A solu- 
tion (0.5 ml) of pyridine and dimethylallylamine (15/1, 
v/v) adjusted with trifluoroacetic acid to pH 9.2, con- 
taining 0.1/A [3H] phenylisothiocyanate/ml was added 
at 45°C. After a certain reaction time, from 0.5-5 min, 
100/al non-labelled phenylisothiocyanate was added 
and incubation was carried out for another 60 min at 
45°C in a nitrogen atmosphere. Subsequently, a nor- 
mal NH2-terminal mino acid analysis was performed. 
The specific radioactivity of the different NHz-termi- 
nal amino acids derivatives were plotted against he 
reaction time (fig.2). The rate of the labelling of NH2- 
terminal methionine, within experimental errors, 
equals that of the other NH2-terminal mino acids 
(Asn, Asp, Glu, Val) in the complex, indicating its 
existence already in the native complex. For simplicity 
only the results with methionine and valine are 
demonstrated in fig.2. 
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Fig.2. Rate of [ 3H] phenylisothiocyanate l b lling of methio- 
nine (= m) as compared tovaline (o - - -o )  in the plasmin- 
%-antiplasmin complex. For details of the experiment see text. 
4. Discussion 
Structural studies on the plasmin--a2-antiplasmin 
complex have indicated that the reactive site in 
a:-antiplasmin constitutes a specific peptide bond in 
the carboxy.terminal portion of the molecule [ 10-12]. 
A peptide of ~8000M r and NH2-terminal methionine, 
originating from the carboxy-terminal end of ct2-anti- 
plasmin could be isolated by gel-filtration of the com- 
plex in the presence of SDS or after treatment with 
diluted NH4OH [10]. The peptide could, however, 
not be isolated by gel-filtration i  10% acetic acid or 
in buffers containing urea or guanidinium-HC1. 
Therefore, we undertook this work to investigate 
whether the reactive-site peptide bond in a2-antiplas- 
min becomes cleaved as a result of complex forma- 
tion with plasmin. From indirect evidence it had been 
suggested that an ester-bond may be of importance in
the stabilization of many protease-inhibitor com- 
plexes, since they are cleaved by agents uch as 
hydroxylamine, benzamidine, weak alkali or methoxy- 
amine [ 1,2,10,21 ]. Of course, a tetrahedral interme- 
diate could not be excluded from these results. 
This study demonstrates a difference in the binding 
of plasmin to a2-antiplasmin ascompared to soybean 
trypsin inhibitor, the former being much more stable. 
Dissociation of the plasmin-soybean trypsin inhibitor 
complex by ct2-antiplasmin releases an intact form of 
soybean trypsin inhibitor. Furthermore, our data 
show that formation of the stable complex between 
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plasmin and ct2-antiplasmin is accompanied by cleav- 
age of the reactive-site peptide bond, since the appear- 
ance of NHrterminal methionine parallels the complex 
formation (fig.l). 
Crystallographic data have suggested that com- 
plexes between trypsin and inhibitors uch as soybean 
trypsin inhibitor or aprotinine are stabilized by the 
formation of a tetrahedral intermediate [5,6]. These 
data were, however, not supported by laC NMR 
studies [22], which rather indicated that non-covalent 
bonds stabilize these inhibitor-protease complexes. 
Our data exclude a tetrahedral intermediate as being 
important in the plasmin-a2-antiplasmin interaction. 
An ester-bond between the hydroxyl-group in the 
active site of plasmin and the carboxyl-group of the 
peptide bond in the reactive site is much more plau- 
sible, in agreement with earlier speculations [ 1,2]. 
However, the explanation for the stability of this 
ester-bonded intermediate is not known, but several 
mechanisms are possible. One explanation may be 
that a very tight complex is formed which does not 
leave any space for the water molecule necessary to 
hydrolyze the ester-bond. However, it has been 
reported that the complex between, e.g., thrombin 
and antithrombin III can be dissociated by benzamidine 
or hydroxylamine [ 1,2] for example. These substances 
do not interfere with the plasmin---ct2-antiplasmin com- 
plex at physiological pH under non-denaturating con- 
dition. Nevertheless, in the presence of SDS, hydroxyl- 
amine seems to cleave the plasmin-~rantiplasmin 
complex (Wiman and Collen, unpublished). Another 
possible explanation of the stability of the ester-bond 
is that cleavage of the reactive site peptide bond 
results in conformational changes, thus interfering 
with the electron-relay system within the catalytic 
center of the enzyme. We have shown that conforma- 
tional changes are likely to occur as a result of com- 
plex formation between and a2-antiplasmin as studied 
by immunochemical [23,24] or spectropolarimetric 
investigations [25]. Work to isolate a fragment from 
the complex containing the bond between plasmin 
and arantiplasmin is in progress. 
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